Venture capital fund
Every published round The Australian Bioscience Trust took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies The Australian Bioscience Trust has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for The Australian Bioscience Trust, as distinct from the investments it has made.
Companies The Australian Bioscience Trust has backed that another company then bought. An exit for the holding, not a deal The Australian Bioscience Trust did.
Stories naming The Australian Bioscience Trust. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
GBS Ventures announces it has fully wound down its 1998 biotech fund with returns in the top quartile of US peers, recalling portfolio listings, Dynamic Hearing's sale to Wolfson, and its $122.5m fourth fund.
GBS Venture Partners closed its third life science fund at $145 million, exceeding its $120 million target, with backing from returning and new Australian institutional investors.